1. Cognitex supplementation in elderly adults with memory complaints: an uncontrolled open label trial.
  2. Yamamoto T, et al. Effect of beer on the plasma concentrations of uridine and purine basesMetabolism. (2002)
  3. Almeida C, et al. Composition of beer by 1H NMR spectroscopy: effects of brewing site and date of productionJ Agric Food Chem. (2006)
  4. Sugawara M, et al. Profile of nucleotides and nucleosides of human milkJ Nutr Sci Vitaminol (Tokyo). (1995)
  5. Thorell L, Sjöberg LB, Hernell O. Nucleotides in human milk: sources and metabolism by the newborn infantPediatr Res. (1996)
  6. Wurtman RJ. Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituentsMetabolism. (2008)
  7. Jonas DA, et al. Safety considerations of DNA in foodAnn Nutr Metab. (2001)
  8. Ka T, et al. Effects of allopurinol on beer-induced increases in plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine)Horm Metab Res. (2006)
  9. Inokuchi T, et al. Effects of allopurinol on beer-induced increases in plasma concentrations of purine bases and uridineNucleosides Nucleotides Nucleic Acids. (2008)
  10. Shetlar MD, Hom K, Venditto VJ. Photohydrate-Mediated Reactions of Uridine, 2′-Deoxyuridine and 2′-Deoxycytidine with Amines at Near Neutral pHPhotochem Photobiol. (2013)
  11. Stene R, Spector R. Effect of a 400-kilocalorie carbohydrate diet on human plasma uridine and hypoxanthine concentrationsBiochem Med Metab Biol. (1987)
  12. Eells JT, Spector R, Huntoon S. Nucleoside and oxypurine homeostasis in adult rabbit cerebrospinal fluid and plasmaJ Neurochem. (1984)
  13. Weinberg ME, et al. Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplementPLoS One. (2011)
  14. Pizzorno G, et al. Homeostatic control of uridine and the role of uridine phosphorylase: a biological and clinical updateBiochim Biophys Acta. (2002)
  15. van Groeningen CJ, et al. Clinical and pharmacologic study of orally administered uridineJ Natl Cancer Inst. (1991)
  16. Venhoff N, et al. Uridine pharmacokinetics of mitocnol, a sugar cane extractAIDS. (2005)
  17. Ashour OM, Naguib FN, el Kouni MH. 5-(m-Benzyloxybenzyl)barbituric acid acyclonucleoside, a uridine phosphorylase inhibitor, and 2′,3′,5′-tri-O-acetyluridine, a prodrug of uridine, as modulators of plasma uridine concentration. Implications for chemotherapyBiochem Pharmacol. (1996)
  18. Acylated uridine and cytidine and uses thereof.
  19. Ashour OM, et al. Effect of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on plasma concentration of uridine released from 2′,3′,5′-tri-O-acetyluridine, a prodrug of uridine: relevance to uridine rescue in chemotherapyCancer Chemother Pharmacol. (2000)
  20. Connolly GP, Duley JA. Uridine and its nucleotides: biological actions, therapeutic potentialsTrends Pharmacol Sci. (1999)
  22. Cornford EM, Oldendorf WH. Independent blood-brain barrier transport systems for nucleic acid precursorsBiochim Biophys Acta. (1975)
  23. Baldwin SA, et al. The equilibrative nucleoside transporter family, SLC29Pflugers Arch. (2004)
  24. Pastor-Anglada M, Felipe A, Casado FJ. Transport and mode of action of nucleoside derivatives used in chemical and antiviral therapiesTrends Pharmacol Sci. (1998)
  25. Gray JH, Owen RP, Giacomini KM. The concentrative nucleoside transporter family, SLC28Pflugers Arch. (2004)
  26. Kong W, Engel K, Wang J. Mammalian nucleoside transportersCurr Drug Metab. (2004)
  27. Podgorska M, Kocbuch K, Pawelczyk T. Recent advances in studies on biochemical and structural properties of equilibrative and concentrative nucleoside transportersActa Biochim Pol. (2005)
  28. Gibellini F, Smith TK. The Kennedy pathway–De novo synthesis of phosphatidylethanolamine and phosphatidylcholineIUBMB Life. (2010)
  29. Vance JE, Vance DE. Phospholipid biosynthesis in mammalian cellsBiochem Cell Biol. (2004)
  30. Fagone P, Jackowski S. Phosphatidylcholine and the CDP-choline cycleBiochim Biophys Acta. (2013)
  31. Aoyama C, Liao H, Ishidate K. Structure and function of choline kinase isoforms in mammalian cellsProg Lipid Res. (2004)
  32. Wu G, Vance DE. Choline kinase and its functionBiochem Cell Biol. (2010)
  33. Jansen SM, et al. Biosynthesis of phosphatidylcholine from a phosphocholine precursor pool derived from the late endosomal/lysosomal degradation of sphingomyelinJ Biol Chem. (2001)
  34. Millington WR, Wurtman RJ. Choline administration elevates brain phosphorylcholine concentrationsJ Neurochem. (1982)
  35. Jackowski S, Fagone P. CTP: Phosphocholine cytidylyltransferase: paving the way from gene to membraneJ Biol Chem. (2005)
  36. Cornell RB, Northwood IC. Regulation of CTP:phosphocholine cytidylyltransferase by amphitropism and relocalizationTrends Biochem Sci. (2000)
  37. Kent C. Regulatory enzymes of phosphatidylcholine biosynthesis: a personal perspectiveBiochim Biophys Acta. (2005)
  38. Choy PC, Paddon HB, Vance DE. An increase in cytoplasmic CTP accelerates the reaction catalyzed by CTP:phosphocholine cytidylyltransferase in poliovirus-infected HeLa cellsJ Biol Chem. (1980)
  39. Vance DE. Boehringer Mannheim Award lecture. Phosphatidylcholine metabolism: masochistic enzymology, metabolic regulation, and lipoprotein assemblyBiochem Cell Biol. (1990)
  40. Jamil H, Utal AK, Vance DE. Evidence that cyclic AMP-induced inhibition of phosphatidylcholine biosynthesis is caused by a decrease in cellular diacylglycerol levels in cultured rat hepatocytesJ Biol Chem. (1992)
  41. Baburina I, Jackowski S. Cellular responses to excess phospholipidJ Biol Chem. (1999)
  42. Cornell RB. Cholinephosphotransferase from mammalian sourcesMethods Enzymol. (1992)
  43. The enzymatic formation of lecithin from cytidine diphosphate choline and D-1,2-diglyceride.
  44. Henneberry AL, Wistow G, McMaster CR. Cloning, genomic organization, and characterization of a human cholinephosphotransferaseJ Biol Chem. (2000)
  45. Henneberry AL, McMaster CR. Cloning and expression of a human choline/ethanolaminephosphotransferase: synthesis of phosphatidylcholine and phosphatidylethanolamineBiochem J. (1999)
  46. Horibata Y, Hirabayashi Y. Identification and characterization of human ethanolaminephosphotransferase1J Lipid Res. (2007)
  47. Richardson UI, et al. Stimulation of CDP-choline synthesis by uridine or cytidine in PC12 rat pheochromocytoma cellsBrain Res. (2003)
  48. Araki W, Wurtman RJ. Control of membrane phosphatidylcholine biosynthesis by diacylglycerol levels in neuronal cells undergoing neurite outgrowthProc Natl Acad Sci U S A. (1997)
  49. Savci V, Wurtman RJ. Effect of cytidine on membrane phospholipid synthesis in rat striatal slicesJ Neurochem. (1995)
  50. G-Coviella IL, Wurtman RJ. Enhancement by cytidine of membrane phospholipid synthesisJ Neurochem. (1992)
  51. Wurtman RJ, et al. Effect of oral CDP-choline on plasma choline and uridine levels in humansBiochem Pharmacol. (2000)
  52. Ulus IH, et al. Cytidine and uridine increase striatal CDP-choline levels without decreasing acetylcholine synthesis or releaseCell Mol Neurobiol. (2006)
  53. Cansev M, et al. Oral uridine-5′-monophosphate (UMP) increases brain CDP-choline levels in gerbilsBrain Res. (2005)
  54. Agarwal N, et al. Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults: a 31-phosphorus magnetic resonance spectroscopy study at 4TBipolar Disord. (2010)
  55. Silveri MM, et al. Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopyNMR Biomed. (2008)
  56. Babb SM, et al. Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy studyPsychopharmacology (Berl). (2002)
  57. Vance JE. Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipidsJ Lipid Res. (2008)
  58. Burnstock G. Physiology and pathophysiology of purinergic neurotransmissionPhysiol Rev. (2007)
  59. Van Poecke S, et al. Synthesis and P2Y₂ receptor agonist activities of uridine 5′-phosphonate analoguesBioorg Med Chem. (2012)
  60. Weisman GA, et al. P2 receptors in health and diseaseBiotechnol Genet Eng Rev. (2006)
  61. Erb L, et al. P2 receptors: intracellular signalingPflugers Arch. (2006)
  62. Pooler AM, et al. Uridine enhances neurite outgrowth in nerve growth factor-differentiated PC12 {corrected}Neuroscience. (2005)
  63. Brunschweiger A, Müller CE. P2 receptors activated by uracil nucleotides–an updateCurr Med Chem. (2006)
  64. P2Y2 Nucleotide Receptors Expressed Heterologously in Sympathetic Neurons Inhibit Both N-Type Ca and M-Type K Currents.
  65. Dobolyi A, et al. Uridine function in the central nervous systemCurr Top Med Chem. (2011)
  66. Zhang Z, et al. P2Y(6) agonist uridine 5′-diphosphate promotes host defense against bacterial infection via monocyte chemoattractant protein-1-mediated monocytes/macrophages recruitmentJ Immunol. (2011)
  67. Kim B, et al. Uridine 5′-diphosphate induces chemokine expression in microglia and astrocytes through activation of the P2Y6 receptorJ Immunol. (2011)
  68. Harden TK, et al. Signalling and pharmacological properties of the P2Y receptorActa Physiol (Oxf). (2010)
  69. Illes P, Alexandre Ribeiro J. Molecular physiology of P2 receptors in the central nervous systemEur J Pharmacol. (2004)
  70. Köles L, et al. P2 receptor signaling in neurons and glial cells of the central nervous systemAdv Pharmacol. (2011)
  71. Erb L, et al. An RGD sequence in the P2Y(2) receptor interacts with alpha(V)beta(3) integrins and is required for G(o)-mediated signal transductionJ Cell Biol. (2001)
  72. Bagchi S, et al. The P2Y2 nucleotide receptor interacts with alphav integrins to activate Go and induce cell migrationJ Biol Chem. (2005)
  73. Arthur DB, Akassoglou K, Insel PA. P2Y2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiationProc Natl Acad Sci U S A. (2005)
  74. Weisman GA, et al. Neuroprotective roles of the P2Y(2) receptorPurinergic Signal. (2012)
  75. Selkoe DJ. Alzheimer’s disease is a synaptic failureScience. (2002)
  76. Terry RD. Alzheimer’s disease and the aging brainJ Geriatr Psychiatry Neurol. (2006)
  77. Spires-Jones TL, et al. Impaired spine stability underlies plaque-related spine loss in an Alzheimer’s disease mouse modelAm J Pathol. (2007)
  78. Wurtman RJ, et al. Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapsesNutr Rev. (2010)
  79. Alvarez VA, Sabatini BL. Anatomical and physiological plasticity of dendritic spinesAnnu Rev Neurosci. (2007)
  80. Arellano JI, et al. Non-synaptic dendritic spines in neocortexNeuroscience. (2007)
  81. Harms KJ, Dunaevsky A. Dendritic spine plasticity: looking beyond developmentBrain Res. (2007)
  82. Wurtman RJ, et al. Use of phosphatide precursors to promote synaptogenesisAnnu Rev Nutr. (2009)
  83. Wurtman RJ, et al. Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orallyBrain Res. (2006)
  84. The efficacy of Souvenaid in mild Alzheimer’s disease: a randomized, controlled, double-blind, parallel group, multi-centre, multi-country clinical trial.
  85. Neary JT, et al. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cellsTrends Neurosci. (1996)
  86. Boglári G, Szeberényi J. Nerve growth factor in combination with second messenger analogues causes neuronal differentiation of PC12 cells expressing a dominant inhibitory Ras protein without inducing activation of extracellular signal-regulated kinasesEur J Neurosci. (2001)
  87. Chuang HH, et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibitionNature. (2001)
  88. Rathbone MP, et al. Trophic effects of purines in neurons and glial cellsProg Neurobiol. (1999)
  89. Wang L, et al. Dietary uridine-5′-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged ratsJ Mol Neurosci. (2005)
  90. Lee V, Trojanowski JQ, Schlaepfer WW. Induction of neurofilament triplet proteins in PC12 cells by nerve growth factorBrain Res. (1982)
  91. Broersen LM, et al. A Specific Multi-Nutrient Diet Reduces Alzheimer-Like Pathology in Young Adult AβPPswe/PS1dE9 MiceJ Alzheimers Dis. (2012)
  92. Open-Label Uridine for Treatment of Depressed Adolescents with Bipolar Disorder.
  93. Jensen JE, et al. Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patientsExp Clin Psychopharmacol. (2008)
  94. Krylova IB, et al. Effect of uridine on energy metabolism, LPO, and antioxidant system in the myocardium under conditions of acute coronary insufficiencyBull Exp Biol Med. (2012)
  95. Nolan D, et al. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapyAIDS. (2003)
  96. McComsey GA, et al. Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229AIDS. (2010)
  97. McComsey GA, et al. Mitochondrial function, inflammation, fat and bone in HIV lipoatrophy: randomized study of uridine supplementation or switch to tenofovirAntivir Ther. (2012)
  98. Sutinen J, et al. Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trialAntivir Ther. (2007)
  99. Choi JH, Ji YG, Lee DH. Uridine Triphosphate Increases Proliferation of Human Cancerous Pancreatic Duct Epithelial Cells by Activating P2Y2 ReceptorPancreas. (2013)
  100. Silver AF, Chase HB. The incorporation of tritiated uridine in hair germ and dermal papilla during dormancy (telogen) and activation (early anagen)J Invest Dermatol. (1977)
  101. Potten CS, Jessup BA, Croxson MB. Incorporation of tritiated thymidine into the skin and hair follicles. II. Daily fluctuations in 3 H-TdR and 3 H-UR levelsCell Tissue Kinet. (1971)
  102. Sims RT. The incorporation of 3H-cytidine into the differentiating cells of the hair cortexJ Anat. (1968)
  103. Greig AV, Linge C, Burnstock G. Purinergic receptors are part of a signalling system for proliferation and differentiation in distinct cell lineages in human anagen hair folliclesPurinergic Signal. (2008)
  104. Dixon CJ, et al. Regulation of epidermal homeostasis through P2Y2 receptorsBr J Pharmacol. (1999)
  105. Greig AV, et al. Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytesJ Invest Dermatol. (2003)
  106. Lee WK, et al. Purinoceptor-mediated calcium mobilization and proliferation in HaCaT keratinocytesJ Dermatol Sci. (2001)
  107. Babb SM, et al. Oral choline increases choline metabolites in human brainPsychiatry Res. (2004)